Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the selection of ...

Calidi Biotherapeutics (NYSE American: CLDI) announced the selection of IL15 superagonist (IL15-IL15Ra) as the first therapeutic payload for its sys ...

Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that in connection ...

Herpesviruses are large enveloped DNA viruses that commonly reactivate during periods of severe immunosuppression. Table 1 lists the management strategies of herpesviruses after SOT. This ...

Calidi Biotherapeutics (NYSE American: CLDI) a clinical-stage biotechnology company advancing targeted antitumor virotherapies, announced the approv ...

Calidi Biotherapeutics Inc. (NYSE American: CLDI) ("Calidi"), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies ...

Calidi’s clinical stage off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient ...

Sexually transmitted infections (STIs) result in millions of cases and cost over $16 billion annually in the U.S. High asymptomatic rates and stigma hinder timely diagnosis and elimination efforts.

“I’m not exaggerating. I was enveloped in a Ready Brek glow of absolute joy, from the soles of my feet to the follicles on the top of my head. “I’ve had some happy moments in farming but ...

As flames from a sizable wildfire in Ocean County stretched across thousands of acres and smoke enveloped the sky, families were right to be worried about the air. Several southern coastal areas ...